Timeline

Isabelle Staropoli
Research Engineer
13 Dec 2023
publication

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.

Read more
28 Feb 2023
publication

Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4+ T Cells.

Read more
14 Feb 2023
publication

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.

Read more
24 Jan 2023
team

Antiviral Activities of Antibodies

Read more
01 Jan 2023
publication

Divergent adaptive immune responses define two types of long COVID.

Read more
17 Nov 2022
publication

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.

Read more
05 Oct 2022
publication

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.

Read more
01 Sep 2022
publication

Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.

Read more
04 Jul 2022
publication

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Read more
17 Jun 2022
news

New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2

Read more
01 Jun 2022
publication

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.

Read more
12 Mar 2022
publication

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.

Read more
01 Feb 2022
publication

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Read more
26 Jan 2022
publication

Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.

Read more
01 Nov 2021
publication

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.

Read more
18 Aug 2021
news

Immune checkpoint inhibitors improve cellular immunity against SARS-CoV-2 infection

Read more
01 Aug 2021
publication

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

Read more
08 Jul 2021
publication

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

Read more
18 May 2021
publication

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.

Read more
01 Apr 2021
publication

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020

Read more
01 Jan 2021
publication

Characteristics Associated with Olfactory and Taste Disorders in COVID-19.

Read more
02 Sep 2020
publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Read more
01 Sep 2020
publication

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

Read more
06 Dec 2018
publication

CCR5 structural plasticity shapes HIV-1 phenotypic properties

Read more
22 Nov 2016
publication

Guidelines for cloning, expression, purification and functional characterization of primary HIV-1 envelope glycoproteins

Read more
03 Jul 2015
project

Viral Pathogenesis Unit’s Project

Read more
18 Jun 2015
publication

A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity

Read more
11 May 2015
team

Virus and Immunity

Read more
22 May 2014
publication

Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry

Read more
21 May 2013
publication

HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines

Read more
26 Jan 2012
publication

Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody

Read more
30 Nov 2010
publication

New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection

Read more
02 Jul 2008
publication

The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins

Read more
01 Jan 2007
publication

The C type lectins DC-SIGN and L-SIGN: receptors for viral glycoproteins

Read more
01 Mar 2006
publication

Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells

Read more
01 May 2005
publication

Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E

Read more
26 Apr 2005
publication

Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals

Read more
10 Mar 2005
publication

Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis

Read more
27 Feb 2003
publication

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

Read more
22 Nov 2002
publication

Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells

Read more
12 Nov 2002
publication

HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains

Read more
26 Feb 2002
publication

Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4

Read more
10 Nov 2000
publication

Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate

Read more
01 Dec 1997
publication

Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice

Read more
01 Feb 1996
publication

Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein

Read more
01 Jul 1994
publication

Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice

Read more